Forget rockets — Longshot wants to fire cargo into space from a gun. See it at TechCrunch Disrupt 2026

Longshot Space Technology has raised about $20 million and is developing multi-injection guns for hypersonic testing and, ultimately, space launches. Its current test gun has accelerated projectiles to Mach 4; the company says a planned 3,000-foot, 30-inch-diameter gun could launch 220-pound payloads at Mach 8, while military contracts may provide testing revenue. CEO Mike Grace estimates that, if the technology scales as intended, launches could cost $50 per kilogram; reaching that goal would require a gun about 10 kilometers long and nearly 10 feet in diameter.

Analysis

Longshot is best viewed as a possible defense-test infrastructure business first and an orbital-launch disruptor only much later. Near term, military hypersonic-target testing could provide a commercial proving ground, but contract scale, renewal terms, utilization, and site costs are not disclosed; the startup’s projected launch economics are company claims, not demonstrated unit economics. A ground accelerator could complement rockets rather than displace them: high acceleration, payload form factor, atmospheric passage, and the need for an onboard second stage likely limit eligible payloads. That makes broad satellite-launch disruption—and any read-through to SpaceX (SPCX)—premature.

Over 1–3 months, watch for independently verifiable contract awards, successful tests at larger scale, and evidence of repeat customer demand. Over 6–18 months, permitting, safety/environmental approvals, facility capex, and payload qualification are likely to matter more than the theoretical energy cost. The contrarian point is that the striking per-kilogram target may anchor attention on launch cost while understating total mission costs and the narrower addressable payload set. This is an early-stage technology signal, not a basis for changing SPCX exposure absent evidence of commercial orbital launches or a material shift in launch pricing.

Key Decisions for Investors

• No direct trade on SPCX from this item: the article provides no evidence of near-term revenue displacement, pricing pressure, or a change in SpaceX’s competitive position.
• Treat Longshot as a defense-testing watch item, not an investable launch thesis yet. Before underwriting it, verify contract value and duration, customer concentration, test cadence, facility economics, and whether larger-scale tests meet independently measured performance claims.
• Set a 1–3 month catalyst watch for additional military awards or demonstrated repeat testing. A lack of follow-on contracts, delays in scaling the test gun, or unresolved site approvals would weaken the near-term commercial case.
• Revisit the orbital-launch thesis only after an end-to-end demonstration with a representative payload and published data on acceleration survivability, delivered payload mass, launch reliability, and total mission cost; absent those milestones, the $/kg claim should not be capitalized as a competitive price.